Isabelle Fournier and her team are out to change surgical oncology.
“Better surgery is associated with better prognosis and higher survival,” said Fournier, a professor at the University of Lille and co-director of a proteomics center of INSERM, the French national institute of health. Her laboratory has worked for several years on a device they call the SpiderMass that will enable surgeons to look for markers of cancer in a living patient’s tissue, during an operation. In an article in Molecular & Cellular Proteomics, the team reports on an important step toward finding protein biomarkers during surgery.
Surgery to remove a primary tumor involves a wait. After the tumor and some healthy surrounding tissue are removed, the surgical team pauses while a pathologist checks the tissue margins under a microscope. Although this process is important for preventing recurrence of the cancer, it can add up to 45 risky minutes under anesthesia.
With the new device, Fournier said, “We think that it is possible to open the way to in vivo real-time proteomics,” which could help surgeons find stray cancer cells faster, perhaps even as they make incisions.
Fournier’s device uses mass spectrometry, which measures the mass of molecules from complex mixtures. But turning an in vivo tissue sample into gas phase ions for measurements can be a challenge. Until now, no one knew how to extract ions from living tissues without doing harm.
So Fournier’s team got creative. Riffing on MALDI, an ionization strategy that uses a carrier molecule mixed with the analyte of interest, they decided to use the water that makes up a majority of human tissue as a carrier to produce a water-assisted laser desorption/ionization, or WALDI. If they could excite the water in a tiny area, it should vaporize, taking ionized organic molecules with it.
“It was an idea at the beginning, and many people thought that it would not work,” Fourier said. “Finally, we have it working beautifully.”
The team built a pulsed laser excitation device tuned to heat water precisely by causing vibration in the oxygen-hydrogen bond. In a 2016 paper, they described using this laser to ionize the outermost layer of tissue, penetrating less than one-twentieth of a millimeter. The human volunteers reported a slight tingling sensation. But the ions that appeared were mostly small molecules and lipids, which are more apt than proteins to adopt a negative charge. The team hoped to measure proteins as well.
In this new paper, Fournier and colleagues report that they have cracked the protein puzzle. By using a more sensitive mass spectrometer and looking for positively instead of negatively charged ions, they found peaks representing purified proteins they had introduced into a cow liver sample. Now that they know the proteins are detectable, the next step will be finding ways to amplify the protein signal over more abundant lipids and metabolites.
In the meantime, the device is already in use for four-legged patients. Fournier’s lab has worked with the veterinary biotech company Oncovet Clinical Research to run a pilot trial, comparing biopsies from pet dogs with sarcoma to healthy tissues. The team developed a lipidomics- and metabolomics-based classification system to robustly identify healthy, necrotic and cancerous tissues. Soon, they will introduce a prototype into a veterinary operating room. If it is successful there, Fournier said, she hopes to reach human clinics, improving tumor removal surgery to give patients better health outcomes.
The Latest on: Proteomics
via Google News
The Latest on: Proteomics
- Global Human Microbiome Market Will Grow at a CAGR of 22.5% - Exclusive Report by MarketsandMarketson September 6, 2019 at 6:18 am
Neurological), Research Technology (Proteomics, Metabolomics) - Global Forecast to 2027", published by MarketsandMarkets™. Microbiomes are responsible for a wide variety of metabolic and developmental ...
- TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinomaon September 3, 2019 at 7:51 am
The exact mechanisms underlying these effects remained unknown. Quantitative proteomics was applied to detect the potential targets of Eukaryotic translation initiation factor 3 subunit b (eIF3b).
- Human Microbiome Market Worth $1,731 Million by 2027 - Exclusive Report by MarketsandMarkets™on September 3, 2019 at 3:30 am
Neurological), Research Technology (Proteomics, Metabolomics) - Global Forecast to 2027", published by MarketsandMarkets™, the Human Microbiome Market is expected to grow from USD 942 million ...
- Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACTon August 30, 2019 at 4:30 am
In fact, our previous study has detected up-regulation of Prx 1 in squamous cervical cancer tissues after NACT relative to the level before chemotherapy by using proteomics profiling . The aim of ...
- Proteomics Market is Expected to Touch a Value of US$ 37 Billion by 2024on August 29, 2019 at 11:43 am
Aug 29, 2019 (Heraldkeepers) -- New York, August 29, 2019: The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the ...
- Decoding the mysteries of da Vinci's paintings with proteomicson August 28, 2019 at 2:02 am
Scientists have used the technique of proteomics to assess the paint blends used in a painting supervised by Leonardo da Vinci. The exercise paves the way for improving the restoration and validation ...
- Proteomics Market Size and Share Worth USD 23.2 Billion | CAGR of 14.1% By 2023on August 26, 2019 at 12:54 am
Global Proteomics Market size and share is expected to reach USD 23.2 billion with expanding at a CAGR of 14.1% over the forecast period (2018 to 2023). The Global proteomics market is expected to ...
- Proteomics Uncovers Potential Markers, Subtypes of Alzheimer’son August 22, 2019 at 3:24 pm
In the last three decades, scientists have made strides in using biomarkers to diagnose Alzheimer’s disease and track its progression. Along with cerebrospinal fluid Aβ, tau, and phospho-tau, a ...
- Cell biology: New proteomics technique gives insights into ubiquitin signalingon August 14, 2019 at 4:11 pm
Researchers have developed a new approach to understand intricate changes that control how proteins function in our cells in health and disease. The new proteomics technique called 'ubiquitin clipping ...
via Bing News